- Research article
- Open Access
Effects of chronic sleep deprivation on bone mass and bone metabolism in rats
- Xiaowen Xu†1,
- Liang Wang†1,
- Liying Chen1,
- Tianjiao Su1,
- Yan Zhang1,
- Tiantian Wang1,
- Weifeng Ma1,
- Fan Yang1,
- Wujie Zhai1,
- Yuanyuan Xie1,
- Dan Li1,
- Qiong Chen1,
- Xuemei Fu1,
- Yuanzheng Ma1Email author and
- Yan Zhang2Email author
© The Author(s). 2016
- Received: 1 June 2016
- Accepted: 13 July 2016
- Published: 2 August 2016
This study aimed to assess the effects of chronic sleep deprivation (CSD) on bone mass and bone metabolism in rats.
Twenty-four rats were randomly divided into CSD and control (CON) groups. Rats were subjected to CSD by using the modified multiple platform method (MMPM) to establish an animal model of CSD. Biochemical parameters such as levels of serum N-terminal propeptide of type I procollagen (PINP), N-terminal cross-linking telopeptide of type I collagen (NTX), growth hormone (GH), estradiol (E2), serum 25(OH)D, and calcium (Ca) were evaluated at 0, 1, 2, and 3 months. After 3 months, each fourth lumbar vertebra and the distal femoral metaphysis of the left extremity of rats were harvested for micro-computed tomography scans and histological analysis, respectively, after the rats were sacrificed under an overdose of pentobarbital sodium.
Compared with rats from the CON group, rats from the CSD group showed significant decreases in bone mineral density (BMD), bone volume over total volume, trabecular bone thickness, and trabecular bone number and significant increases in bone surface area over bone volume and trabecular bone separations (P < 0.05). Bone histomorphology studies showed that rats in the CSD group had decreased osteogenesis, impaired mineralization of newly formed bones, and deteriorative trabecular bone in the secondary spongiosa zone. In addition, they showed significantly decreased levels of serum PINP (1 month later) and NTX (3 months later) (P < 0.05). The serum 25(OH)D level of rats from the CSD group was lower than that of rats from the CON group after 1 month (P < 0.05).
CSD markedly affects bone health by decreasing BMD and 25(OH)D, deteriorating the bone microarchitecture, and decreasing bone formation and bone resorption markers.
- Chronic sleep deprivation
- Bone mineral density
- Bone microstructure
- Bone turnover
- Vitamin D
The American National Sleep Foundation recommends that healthy adults sleep for 7–9 h/day. However, an increasing number of people are having insufficient sleep, and approximately one third of adults report getting less than 6.5 h of sleep on each weeknight . Owing to factors such as long working hours, internet and media use, stressful lifestyle, increased exposure to environmental light, and longer commuting time, more adults experience chronic sleep deprivation (CSD) in modern society . Yang et al. reported that adolescents, who sleep approximately 4.86–5.62 h per day because of academic demands or stress and early school start times, also suffer from sleep deprivation . Moreover, sleep problems increase with age. Several factors such as poor sleep hygiene, depression, use of medications, and comorbidities lead to disturbed sleep in elderly people, with 67 % of adults aged 65 years and older having at least one sleep-related complaint [4, 5]. Chronic sleep deprivation, owing to both short sleep duration and poor sleep quality, may contribute to problems in sustained attention, cognitive slowing , circadian rhythm disorders , cardiovascular disease , and increased risk of diabetes  and metabolic syndrome .
CSD has been reported to be associated with lower vitamin D concentrations . Some clinical studies have shown that inadequate sleep duration and/or lower sleep efficiency is associated with lower vitamin D levels in elderly adults or older men [12–14]. Vitamin D affects intestinal calcium absorption and helps maintain the state of normocalcemia. It is an important hormone for bone health. A low serum 25(OH)D level is significantly associated with low bone mineral density (BMD). Therefore, some researchers have recently focused on the association between chronic sleep disturbances and BMD [15–21]. Several epidemiologic studies have shown that CSD leads to decreased BMD [15–18]. It has been reported that compared to individuals who sleep for 8 h, those who sleep for 6 h or less have significantly lower total and regional BMD . Another clinical survey showed that patients with sleep disorders, particularly women and elderly people, have an increased risk of osteoporosis . Similarly, young adults and children with poor sleep quality or short sleep duration have lower BMD and worse bone mass accrual, especially during periods of rapid growth [17, 18]. Several studies have suggested that CSD is associated with lower BMD; however, one study showed that sleeping for both less than and more than 8–9 h/day increases the risks of having osteoporosis . In addition, some studies showed that the association between sleep duration and BMD was not significant [20, 21].
Previous clinical studies have failed to reach a consensus on the association between sleep duration and BMD, and have not indicated bone metabolic status and the related possible mechanisms associated with CSD. Owing to the difficulty in controlling diet and sleep behavior in humans through long periods of clinical research, animal laboratory studies are critical. Further animal laboratory studies are warranted to determine the relationship of short sleep duration with bone mass and bone metabolism. Thus, the present study aimed to explore the effects of long-term CSD on bone mass and bone metabolism in rats, and to further investigate the related possible mechanism. The modified multiple platform method (MMPM), as described in previous studies [22, 23], was selected to induce CSD. During the 3-month intervention of CSD, the lumbar spines of rats were subjected to micro-computed tomography (micro-CT) scans, the bone histomorphology of the left femur was analyzed, and serum levels of bone turnover markers, growth hormone (GH), estradiol (E2), serum 25(OH)D, and calcium (Ca) were evaluated.
Animals and experimental design
Twenty-four 5-month-old female Sprague-Dawley (SD) rats obtained from the Laboratory Animal Center of Military Medical Science Academy of PLA, Beijing, China, were randomly divided into chronic sleep deprivation (CSD) group (n = 12) and control (CON) group (n = 12). All animals were housed in six cages, with four rats in each cage, and kept under constant environmental conditions (22–24 °C, 12 h per day light/dark cycles). Food and water were offered ad libitum, except during the 12-h fasting period before the collection of blood samples. The body weight of the animals was measured once a week. After adapting to laboratory conditions for 30 min per day for 1 week, rats from the CSD group were placed on multiple small platforms, as described in the experimental procedure, while rats from the CON group were placed on a grid under the same conditions. The fasting blood samples were collected from the angular vein plexus between 08:00 and 10:00 h at 0, 1, 2, and 3 months, centrifuged at 1500×g for 10 min at 4 °C, and the serum sample was stored immediately at −80 °C for measurement of biochemical parameters. After 3 months, the rats were sacrificed under an overdose of pentobarbital sodium. The fourth lumbar vertebra  was harvested for micro-CT analysis, and the left femur was fixed in phosphate-buffered formaldehyde for histomorphological analysis. This study was carried out in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. The animal use protocol has been reviewed and approved by the Ethics Committee of the 309th Hospital of PLA (number: 2015-13).
Chronic sleep deprivation
The MMPM, illustrated elsewhere [23, 25], was selected to build the CSD model in this study. Rats from the CSD group were group housed (six rats in each arena) in modified multiple platform arenas during periods of sleep deprivation. The water tank (123 × 44 × 44 cm3), made of organic glass, contained 12 narrow circular platforms (6.5 cm in diameter) filled with water up to 1 cm of their upper surface. Thus, rats from the CSD group could move around freely inside the tank by jumping from one platform to another. When they reached the paradoxical phase of sleep, muscle atonia set in; their faces touched the water, and they awoke. Thus, the CSD models were built by depriving the rats of their paradoxical sleep. The housing condition for rats from the CON group was similar, but there was a grid floor covering on the narrow circular platforms. The grid floor was made of stainless steel, with the rods set 2 cm apart. This could provide a different environment for rats from the CON group, where they could lie down without falling into the water, while their tails may touch the water.
After a 1-week adaptation period, rats from the CSD group were sleep-deprived using the MMPM for 18 h (starting at 16:00 h) per day for 3 months. The animals were allowed to sleep in their individual home cages for the remaining time (6 h, 10:00–16:00 h). During a 3-month environmental period, the conditions in the water were kept constant (22–24 °C, 12 h per day light/dark cycles) and the water in the tank was changed daily. When all rats were housed in modified multiple platform arenas, chow pellets and water bottles were placed at the top of the tank, where the rats could freely access food and water.
The excised vertebrae (L4) were thawed at room temperature for 2 h before scanning. The bone microstructures of the fourth lumbar vertebrae were determined using a micro-CT with an Inveon Multimodality Imaging System (Siemens, Munich, Germany). The samples, placed in the sample holder of the scanner, were scanned along the longitudinal axis of the specimen, using the following scanning parameters: voltage of 80 kV, current of 500 μA, effective pixel size of 8.82 μm, and exposure time of 1500 ms in each of the 360 rotational steps . The COBRA_Exxim system was used for image reconstruction. Parameters such as BMD, bone volume over total volume (BV/TV), bone surface area over bone volume (BS/BV), trabecular bone thickness (Tb.Th), trabecular bone number (Tb.N), and trabecular bone separations (Tb.Sp) were calculated using the Inveon Research Workplace (Siemens). Trabecular bone was determined by a fixed threshold. The interest region of lumbar vertebrae was isolated by hand-drawn contours based on approximately 200 consecutive slices (1.7 mm below the superior endplate of the lumbar vertebrae).
The left femurs were decalcified in 10 % ethylenediaminetetraacetic acid (EDTA) (pH 7.4) for 2 months. They were then dehydrated using ethanol solutions and embedded in paraffin by using standard histological procedures. Sections of 4 μm were cut and stained with hematoxylin and eosin (H&E). Bone histology was evaluated using a microscope (Leica DM 2500). The images of chondrocyte zone at the growth plate and primary and secondary spongiosa at the distal femoral metaphysis of the extremities were captured.
Serum biochemical parameters
Serum N-terminal propeptide of type I procollagen (PINP) was measured as bone-formation marker, while N-terminal cross-linking telopeptide of type I collagen (NTX) was selected as a bone resorption marker. Both PINP and NTX were measured using specific enzyme-linked immunosorbent assay (ELISA) kits (Beijing bioco Laibo Technology Co. Ltd., China). The intra- and inter-assay coefficients of variation for PINP were <7 and <8 %, respectively, and those for NTX were <6 and <10 %, respectively.
To explore the related possible mechanism, the changes in serum levels of GH and E2 as well as that of serum 25(OH)D, an important hormone linked with bone metabolism, were analyzed using ELISA kits (Beijing bioco Laibo Technology). In addition, serum calcium (Ca) levels were measured by a Beckman Coulter AU5800 clinical chemistry analyzer (USA).
Data were presented as means ± standard deviation. The independent two-sample t test was used to identify significant differences between rats from the CSD and CON groups. All statistical comparisons were performed using SPSS (version 17.0). Statistical significance was set as P < 0.05.
Bone mass and bone microstructure analysis
Trabecular bone parameters of the fourth lumbar vertebrae measured by micro-CT
1312.33 ± 8.94
1358.18 ± 10.15
26.43 ± 3.51
35.00 ± 4.67
33.27 ± 2.49
30.51 ± 2.51
0.061 ± 0.003
0.069 ± 0.005
4.45 ± 0.31
4.95 ± 0.34
0.20 ± 0.02
0.17 ± 0.03
Serum biochemical parameters
The serum levels of GH, E2, and Ca showed no significant changes during the experiment, and the differences between their levels in rats from the CSD and CON groups were not significant (Fig. 4c, d, f; P > 0.05). The changes in the serum levels of 25(OH)D are shown in Fig. 4e. Compared to rats from the CON group, those from the CSD group showed significantly decreased levels of serum 25(OH)D after 1 month of CSD (P < 0.05).
In the present study, we observed that CSD resulted in lower bone mass and deterioration of bone microarchitecture, including significant decreases in BMD, BV/TV, Tb.Th, and Tb.N, and significant increases in BS/BV and Tb.Sp. Bone histomorphology studies showed that rats from the CSD group had decreased osteogenesis, impaired mineralization of the newly formed bones, and deteriorative trabecular bone in the secondary spongiosa zone. Both bone formation and resorption marker levels (PINP and NTX) were significantly decreased, suggesting a low bone turnover after 3 months of CSD, which could be attributed to the decreased serum levels of 25(OH)D observed after 1 month of CSD. However, the serum levels of GH, E2, and Ca showed no significant changes during the experiment, and the differences between their levels in rats from the CSD and CON groups were not significant. In addition, the body weights of rats from both groups increased over time; however, CSD resulted in attenuation of weight gain after 1 week of sleep deprivation.
Although several clinical studies showed an association between sleep duration and BMD, the conclusions have not reached a consensus. Specker et al.  reported that compared to women who got adequate sleep (>6.5–10 h/night), sleep-deprived women (<6.5 h/night) had lower cortical volumetric BMD after adjustment for potential covariates, such as age, weight, height, physical activity, and intakes of fat, calcium, and vitamin D. Fu et al.  reported that compared to individuals who slept for 8 h, those who slept for a shorter duration of 6 h or less had significantly lower total and regional BMD. Similar results were reported in other studies on children and young adults; those with poorer sleep quality or shorter sleep duration also had lower BMD and worse bone mass accrual, especially during periods of rapid growth [17, 18]. In contrast, Nakagi et al.  reported that sleep duration was not significantly correlated with BMD. Another study also did not support the association between shorter sleep duration and lower BMD levels in older adults. The study indicated that men, but not women, who slept for ≥9 h/day had significantly lower femoral neck BMD than those who slept for 8 h/day after adjusting for age, education level, smoking, physical activity, depressive symptomatology, comorbidity, and serum vitamin D concentration; however, the association was weak and showed no significant difference after further adjustment for urinary cortisol and serum inflammation biomarkers . Another large-scale cross-sectional study suggested that both shorter (7–8 h/day) and longer (9–10 h/day and ≥10 h) sleep duration tends to increase the risk of osteoporosis in postmenopausal women . They provided two possible reasons for the effect of longer sleep on bone. One explanation was that the increase in total sleep duration during the day would reduce the time that could be spent doing physical exercise or labor. Another explanation was that the longer sleep may be a consequence associated with the influence of chronic disease. However, an animal laboratory study on the relationship between shorter sleep duration and BMD showed that new bone formation in sleep-restricted rats decreased without reduction in bone resorption, leading to osteopenia . This finding is consistent with that of the present study, which showed that rats with CSD had lower bone mass. Nevertheless, both bone formation and resorption in rats significantly decreased in our study; further studies are warranted to confirm the effects of bone metabolism. A previous study reported that the histomorphometric determinations of bone formation, such as growth plate or cortical bone thicknesses observed in pathologic pictures, showed no statistically significant difference between sleep-restricted rats and controls. In contrast, we used micro-CT, which has been acknowledged as an effective technique for investigating the microarchitecture of bone for excised applications , to evaluate the microarchitecture of each fourth lumbar vertebra. We found remarkably deteriorating bone microarchitecture in rats from the CSD group compared with controls, including significant decreases in BV/TV, Tb.Th, and Tb.N and significant increases in BS/BV and Tb.Sp. Bone histomorphology of the distal femoral metaphysis of the extremity demonstrated that rats from the CSD group showed decreased osteogenesis, impaired mineralization of the newly formed bones, and deteriorative trabecular bone in the secondary spongiosa zone.
Circadian rhythm disruption was a routine consequence of CSD. It was reported that CSD may lead to GH deficit . GH is an important regulator of postnatal growth and bone mass. It has been reported that GH can improve bone mass and increase the mechanical strength of bone in glucocorticoid-induced/aged ovariectomized osteopenic and normal rodents [32, 33]. Grubbe et al.  reported a similar result that GH mitigates loss of periosteal bone formation and muscle mass in disuse osteopenic rats. Further, Iglesias et al. reported that GH deficiency, established by hypophysectomy, results in cessation of bone growth and a decrease in cancellous bone mass . However, our study did not find any significant difference of GH between rats from the CSD and CON groups. This could be attributed to fluctuations in the serum GH level during the long-term collection of fasting blood samples in our experimental design. Owing to the relatively small sample size in our experiment, further large-sample experiments are required. Sex hormone is another important regulator of bone mass. Estrogen deficiency could increase the risk of osteoporosis in postmenopausal women. It has been reported that serum estrogen level of paradoxical sleep-deprived rats was lower than that of normal rats . Nonetheless, as the growth hormone, the difference of E2 between rats from the CSD and CON groups was not significant in the present study.
Vitamin D is an important hormone for bone health. It affects intestinal calcium absorption and maintains the state of normocalcemia. Low serum 25(OH)D level was reported to be significantly correlated with low BMD and increased risk of non-vertebral and hip fracture [37–39]. Vitamin D deficiency in children causes rickets, while in adults, it may lead to osteomalacia. Limited clinical studies have shown the association between vitamin D level, and sleep duration and quality. Kim et al.  reported that inadequate sleep duration is associated with lower vitamin D levels in elderly people. Massa et al.  reported that low serum 25(OH)D level in older men is related with poorer sleep, which is a combination of short sleep duration and low sleep efficiency. In contrast, Gunduz et al.  reported that despite the prevalence of insufficient vitamin D and poor sleep quality in pregnant women, low levels of vitamin D are not associated with poor sleep quality. However, in the present study, rats from the CSD group showed significantly decreased levels of serum 25(OH)D after 1 month of CSD. The low serum 25(OH)D level in these rats may be an important factor responsible for the lower bone mass, deteriorated bone microarchitecture, and low bone turnover.
We also found that the body weights of rats from both groups increased over time; however, CSD resulted in attenuation of weight gain after 1 week of sleep deprivation. A similar result was observed in previous studies, where sleep-deprived rats lost 15 % of their body weight, whereas their food intake increased 2- to 3-fold [29, 41]. This negative energy balance may have an adverse effect on bone formation. It has been reported that the negative energy balance induced an inverse effect on osteocalcin concentrations . Yamamoto et al.  found that hypermetabolism induced by thyroid hormone administration results in osteopenia. In the present study, rats from the CSD group showed decreased bone mass, suggesting the involvement of negative energy balance in the effect of CSD on bone mass. Further studies are warranted to explore the possible mechanism. In addition, in this study, the serum levels of Ca showed no significant changes during the experiment, and the differences in Ca levels between rats from the CSD and CON groups were not significant. This could be attributed to the strict regulation of serum Ca level by using multiple approaches to maintain steady concentration with little fluctuation.
Some studies have reported that chronic poor sleep may contribute to chronic low-grade inflammation [44, 45]. This inflammation is associated with an increased risk for osteoporosis. Smith et al. developed an in vivo model of bone loss induced by chronic systemic inflammation by using SD rats, and observed upregulation of proinflammatory mediators such as cyclooxygenase (COX)-2, interleukin (IL)-1, and tumor necrosis factor (TNF)-alpha in the metaphyseal region . Jurado et al. reported that IL-1beta treatment could increase the level of OPG mRNA in primary human osteoblastic cell . D’Amelio et al. found that estrogen deficiency enhances the production of the pro-osteoclastogenetic cytokine TNF-alpha, and observed that T cells and monocytes from women with osteoporosis exhibit a higher production of TNF-alpha . Oxidative stress, caused by increased reactive oxygen species, has a negative age-related effect on BMD in rats and could accelerate bone deterioration in aged rats . The possible reason is that it could inhibit the proliferation and differentiation of rat osteoblasts. These studies indicate the involvement of some inflammatory cytokines in the effect of CSD on bone health. However, we did not detect inflammatory cytokines in this study. Further studies are warranted to evaluate the role of inflammatory cytokines in the effect of CSD on bone health.
Some hypotheses were proposed to explain the effects of CSD on bone mass and bone metabolism. It was reported that the skeleton may be a ductless gland that could produce a hormone responding to environmental influences of metabolism and energy requirements. The bone hormone, in cooperation with other hormones, may regulate phosphate metabolism and influence skeletal mineralization [50, 51]. Meanwhile, the CSD rat model of MMPM could disturb the endocrine system. The bone hormone may be disturbed by CSD, influencing the bone mass and bone metabolism. In addition, the sleep loss and sleep disturbances could accelerate the senescence process [52, 53], which is an important risk factor for osteoporosis with low bone transformation. Thus, CSD may lead to low bone transformation and reduced bone mass by accelerating the senescence process. The results of this study were consistent with the proposed hypotheses.
Some limitations of the present study deserve attention. First, despite evaluating the effect of a short sleep duration of 6 h on bone mass and bone metabolism, the extent of restrictive sleep durations was not considered in the present study. Several groups of different sleep durations should be established in future studies. Second, the changes in bone mass, bone microarchitecture, and serum biochemical parameters after the recovery of sleep for several months were not analyzed. It is unclear whether the effect of CSD on bone health is a reversible process. Third, since the serum levels of GH, E2, and Ca were found to fluctuate at different times within 24 h, the fasting blood samples, collected between 08:00 and 10:00 h, could not entirely represent the status of GH, E2, and Ca in rats. A more rational experimental design should be applied in future studies. Finally, the sample size of this study was relatively small, whereas the standard deviation was a little large; thus, the results should be explained with caution, and a larger sample should be used in future studies.
In conclusion, our data reveal that CSD markedly affects bone mass and bone metabolism, by lowering BMD, deteriorating bone microarchitecture, and decreasing bone formation and resorption markers. Serum levels of 25(OH)D decreased after 1 month of chronic sleep deprivation, whereas the serum levels of GH, E2, and Ca showed no significant changes during the experiment. It is recommended that a good sleep pattern be maintained for optimal bone health. Further studies are warranted to confirm the association between CSD and bone health, and to explain the potential mechanism underlying the effects of CSD on bone health.
BMD, bone mineral density; Ca, calcium; CON, control; CSD, chronic sleep deprivation; GH, growth hormone; micro-CT, micro-computed tomography; MMPM, modified multiple platform method
We thank the 309th Hospital of PLA for the support.
The study was not funded.
Availability of data and materials
The data of this study were real and were performed in SPSS (Version 17.0). The statistical results of the data are presented in this main paper. The images of case examples are depicted in this research article.
XX, LW, YM, and YZ contributed to the conception and design of the study. XX, LW, LC, TS, YZ, TW, WM, FY, WZ, YX, DL, QC, and XF acquired and analyzed the data. XX, LW, YM, and YZ contributed to interpretation of the data. XX and LW wrote the first version of the manuscript, and YM and YZ revised it critically for intellectual content. All authors read and approved the final manuscript. All authors agree to be accountable for all aspects of the work.
The authors declare that they have no competing interests.
Consent for publication
Ethics approval and consent to participate
This study was conducted in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. The animal use protocol has been reviewed and approved by the Ethics Committee of the 309th Hospital of PLA (number: 2015-13).
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
- Bonnet MH, Arand DL. We are chronically sleep deprived. Sleep. 1995;18:908–11.PubMedGoogle Scholar
- Worthman CM, Brown RA. Sleep budgets in a globalizing world: biocultural interactions influence sleep sufficiency among Egyptian families. Soc Sci Med. 2013;79:31–9.View ArticlePubMedGoogle Scholar
- Yang CK, Kim JK, Patel SR, Lee JH. Age-related changes in sleep/wake patterns among Korean teenagers. Pediatrics. 2005;115:250–6.View ArticlePubMedGoogle Scholar
- Foley D, Ancoli-Israel S, Britz P, Walsh J. Sleep disturbances and chronic disease in older adults: results of the 2003 National Sleep Foundation Sleep in America Survey. J Psychosom Res. 2004;56:497–502.View ArticlePubMedGoogle Scholar
- Ancoli-Israel S. Sleep and aging: prevalence of disturbed sleep and treatment considerations in older adults. J Clin Psychiatry. 2005;66:24–30. quiz 42-3.PubMedGoogle Scholar
- Scott JP, McNaughton LR, Polman RC. Effects of sleep deprivation and exercise on cognitive, motor performance and mood. Physiol Behav. 2006;87:396–408.View ArticlePubMedGoogle Scholar
- McEwen BS. Sleep deprivation as a neurobiologic and physiologic stressor: allostasis and allostatic load. Metabolism. 2006;55:S20–3.View ArticlePubMedGoogle Scholar
- Dominguez-Rodriguez A, Abreu-Gonzalez P. The link between sleep duration and inflammation: effects on cardiovascular disease. Int J Cardiol. 2014;173:600–1.View ArticlePubMedGoogle Scholar
- Heianza Y, Kato K, Fujihara K, Tanaka S, Kodama S, Hanyu O, et al. Role of sleep duration as a risk factor for Type 2 diabetes among adults of different ages in Japan: the Niigata Wellness Study. Diabet Med. 2014;31:1363–7.View ArticlePubMedGoogle Scholar
- Troxel WM, Buysse DJ, Matthews KA, Kip KE, Strollo PJ, Hall M, et al. Sleep symptoms predict the development of the metabolic syndrome. Sleep. 2010;33:1633–40.PubMedPubMed CentralGoogle Scholar
- Evatt ML. Vitamin D, associations and sleep physiology-promising rays of information. Sleep. 2015;38:171–2.PubMedPubMed CentralGoogle Scholar
- Blank JB, Cawthon PM, Carrion-Petersen ML, Harper L, Johnson JP, Mitson E, et al. Overview of recruitment for the osteoporotic fractures in men study (MrOS). Contemp Clin Trials. 2005;26:557–68.View ArticlePubMedGoogle Scholar
- Kim JH, Chang JH, Kim DY, Kang JW. Association between self-reported sleep duration and serum vitamin D level in elderly Korean adults. J Am Geriatr Soc. 2014;62:2327–32.View ArticlePubMedGoogle Scholar
- Massa J, Stone KL, Wei EK, Harrison SL, Barrett-Connor E, Lane NE, et al. Vitamin D and actigraphic sleep outcomes in older community-dwelling men: the MrOS sleep study. Sleep. 2015;38:251–7.PubMedPubMed CentralGoogle Scholar
- Fu X, Zhao X, Lu H, Jiang F, Ma X, Zhu S. Association between sleep duration and bone mineral density in Chinese women. Bone. 2011;49:1062–6.View ArticlePubMedGoogle Scholar
- Yen CM, Kuo CL, Lin MC, Lee CF, Lin KY, Lin CL, et al. Sleep disorders increase the risk of osteoporosis: a nationwide population-based cohort study. Sleep Med. 2014;15:1339–44.View ArticlePubMedGoogle Scholar
- Casazza K, Hanks LJ, Fernandez JR. Shorter sleep may be a risk factor for impaired bone mass accrual in childhood. J Clin Densitom. 2011;14:453–7.View ArticlePubMedPubMed CentralGoogle Scholar
- Zakhem E, El Hage R, Zunquin G, Jacob C, Moussa E, Theunynck D. Sleep quality is a determinant of hip bone mineral density in a group of young Lebanese men. J Med Liban. 2014;62:213–6.PubMedGoogle Scholar
- Chen G, Chen L, Wen J, Yao J, Li L, Lin L, et al. Associations between sleep duration, daytime nap duration, and osteoporosis vary by sex, menopause, and sleep quality. J Clin Endocrinol Metab. 2014;99:2869–77.View ArticlePubMedGoogle Scholar
- Nakagi Y, Ito T, Hirooka K, Sugioka Y, Endo H, Saijo Y, et al. Association between lifestyle habits and bone mineral density in Japanese juveniles. Environ Health Prev Med. 2010;15:222–8.View ArticlePubMedPubMed CentralGoogle Scholar
- Kobayashi D, Takahashi O, Deshpande GA, Shimbo T, Fukui T. Association between osteoporosis and sleep duration in healthy middle-aged and elderly adults: a large-scale, cross-sectional study in Japan. Sleep Breath. 2012;16:579–83.View ArticlePubMedGoogle Scholar
- Harness DM, Donlon WC, Eversole LR. Comparison of clinical characteristics in myogenic, TMJ internal derangement and atypical facial pain patients. Clin J Pain. 1990;6:4–17.View ArticlePubMedGoogle Scholar
- Ma C, Wu G, Wang Z, Wang P, Wu L, Zhu G, et al. Effects of chronic sleep deprivation on the extracellular signal-regulated kinase pathway in the temporomandibular joint of rats. PLoS One. 2014;9, e107544.View ArticlePubMedPubMed CentralGoogle Scholar
- Yoon KH, Cho DC, Yu SH, Kim KT, Jeon Y, Sung JK. The change of bone metabolism in ovariectomized rats: analyses of MicroCT scan and biochemical markers of bone turnover. J Korean Neurosurg Soc. 2012;51:323–7.View ArticlePubMedPubMed CentralGoogle Scholar
- Oh MM, Kim JW, Jin MH, Kim JJ, du Moon G. Influence of paradoxical sleep deprivation and sleep recovery on testosterone level in rats of different ages. Asian J Androl. 2012;14:330–4.View ArticlePubMedGoogle Scholar
- Shuai B, Shen L, Yang Y, Ma C, Zhu R, Xu X. Assessment of the impact of zoledronic acid on ovariectomized osteoporosis model using micro-CT scanning. PLoS One. 2015;10, e0132104.View ArticlePubMedPubMed CentralGoogle Scholar
- Specker BL, Binkley T, Vukovich M, Beare T. Volumetric bone mineral density and bone size in sleep-deprived individuals. Osteoporos Int. 2007;18:93–9.View ArticlePubMedGoogle Scholar
- Niu J, Sahni S, Liao S, Tucker KL, Dawson-Hughes B, Gao X. Association between sleep duration, insomnia symptoms and bone mineral density in older Boston Puerto Rican adults. PLoS One. 2015;10, e0132342.View ArticlePubMedPubMed CentralGoogle Scholar
- Everson CA, Folley AE, Toth JM. Chronically inadequate sleep results in abnormal bone formation and abnormal bone marrow in rats. Exp Biol Med (Maywood). 2012;237:1101–9.View ArticleGoogle Scholar
- Wu Y, Adeeb S, Doschak MR. Using micro-CT derived bone microarchitecture to analyze bone stiffness—a case study on osteoporosis rat bone. Front Endocrinol (Lausanne). 2015;6:80.Google Scholar
- Lieb K, Reincke M, Riemann D, Voderholzer U. Sleep deprivation and growth-hormone secretion. Lancet. 2000;356:2096–7.View ArticlePubMedGoogle Scholar
- Ortoft G, Andreassen TT, Oxlund H. Growth hormone increases cortical and cancellous bone mass in young growing rats with glucocorticoid-induced osteopenia. J Bone Miner Res. 1999;14:710–21.View ArticlePubMedGoogle Scholar
- Andreassen TT, Oxlund H. The influence of combined parathyroid hormone and growth hormone treatment on cortical bone in aged ovariectomized rats. J Bone Miner Res. 2000;15:2266–75.View ArticlePubMedGoogle Scholar
- Grubbe MC, Thomsen JS, Nyengaard JR, Duruox M, Brüel A. Growth hormone mitigates loss of periosteal bone formation and muscle mass in disuse osteopenic rats. J Musculoskelet Neuronal Interact. 2014;14:473–83.PubMedGoogle Scholar
- Iglesias L, Yeh JK, Castro-Magana M, Aloia JF. Effects of growth hormone on bone modeling and remodeling in hypophysectomized young female rats: a bone histomorphometric study. J Bone Miner Metab. 2011;29:159–67.View ArticlePubMedGoogle Scholar
- Antunes IB, Andersen ML, Baracat EC, Tufik S. The effects of paradoxical sleep deprivation on estrous cycles of the female rats. Horm Behav. 2006;49:433–40.View ArticlePubMedGoogle Scholar
- Bischoff-Ferrari HA, Kiel DP, Dawson-Hughes B, Orav JE, Li R, Spiegelman D, et al. Dietary calcium and serum 25-hydroxyvitamin D status in relation to BMD among U.S. adults. J Bone Miner Res. 2009;24:935–42.View ArticlePubMedGoogle Scholar
- Bischoff-Ferrari HA, Willett WC, Wong JB, Stuck AE, Staehelin HB, Orav EJ, et al. Prevention of nonvertebral fractures with oral vitamin D and dose dependency: a meta-analysis of randomized controlled trials. Arch Intern Med. 2009;169:551–61.View ArticlePubMedGoogle Scholar
- Holvik K, Gjesdal CG, Tell GS, Grimnes G, Schei B, Apalset EM, et al. Low serum concentrations of alpha-tocopherol are associated with increased risk of hip fracture. A NOREPOS study. Osteoporos Int. 2014;25:2545–54.View ArticlePubMedGoogle Scholar
- Gunduz S, Kosger H, Aldemir S, Akcal B, Tevrizci H, Hizli D, et al. Sleep deprivation in the last trimester of pregnancy and inadequate vitamin D: is there a relationship? J Chin Med Assoc. 2016;79:34–8.View ArticlePubMedGoogle Scholar
- Everson CA, Szabo A. Recurrent restriction of sleep and inadequate recuperation induce both adaptive changes and pathological outcomes. Am J Physiol Regul Integr Comp Physiol. 2009;297:R1430–40.View ArticlePubMedPubMed CentralGoogle Scholar
- Jürimäe J, Rämson R, Mäestu J, Jürimäe T, Arciero PJ, Braun WA, et al. Interactions between adipose, bone, and muscle tissue markers during acute negative energy balance in male rowers. J Sports Med Phys Fitness. 2011;51:347–54.PubMedGoogle Scholar
- Yamamoto M, Markatos A, Seedor JG, Masarachia P, Gentile M, Rodan GA, et al. The effects of the aminobisphosphonate alendronate on thyroid hormone-induced osteopenia in rats. Calcif Tissue Int. 1993;53:278–82.View ArticlePubMedGoogle Scholar
- Okun ML, Coussons-Read M, Hall M. Disturbed sleep is associated with increased C-reactive protein in young women. Brain Behav Immun. 2009;23:351–4.View ArticlePubMedGoogle Scholar
- Irwin MR. Why sleep is important for health: a psychoneuroimmunology perspective. Annu Rev Psychol. 2015;66:143–72.View ArticlePubMedGoogle Scholar
- Smith BJ, Lerner MR, Bu SY, Lucas EA, Hanas JS, Lightfoot SA, et al. Systemic bone loss and induction of coronary vessel disease in a rat model of chronic inflammation. Bone. 2006;38:378–86.View ArticlePubMedGoogle Scholar
- Jurado S, Garcia-Giralt N, Díez-Pérez A, Esbrit P, Yoskovitz G, Agueda L, et al. Effect of IL-1beta, PGE(2), and TGF-beta1 on the expression of OPG and RANKL in normal and osteoporotic primary human osteoblasts. J Cell Biochem. 2010;110:304–10.PubMedGoogle Scholar
- D’Amelio P, Grimaldi A, Di Bella S, Brianza SZ, Cristofaro MA, Tamone C, et al. Estrogen deficiency increases osteoclastogenesis up-regulating T cells activity: a key mechanism in osteoporosis. Bone. 2008;43:92–100.View ArticlePubMedGoogle Scholar
- Wu Q, Zhong ZM, Pan Y, Zeng JH, Zheng S, Zhu SY, et al. Advanced oxidation protein products as a novel marker of oxidative stress in postmenopausal osteoporosis. Med Sci Monit. 2015;21:2428–32.View ArticlePubMedPubMed CentralGoogle Scholar
- Guntur AR, Rosen CJ. Bone as an endocrine organ. Endocr Pract. 2012;18:758–62.View ArticlePubMedPubMed CentralGoogle Scholar
- Vervloet MG, Massy ZA, Brandenburg VM, Mazzaferro S, Cozzolino M, Ureña-Torres P, et al. Bone: a new endocrine organ at the heart of chronic kidney disease and mineral and bone disorders. Lancet Diabetes Endocrinol. 2014;2:427–36.View ArticlePubMedGoogle Scholar
- Tempaku PF, Mazzotti DR, Tufik S. Telomere length as a marker of sleep loss and sleep disturbances: a potential link between sleep and cellular senescence. Sleep Med. 2015;16:559–63.View ArticlePubMedGoogle Scholar
- Pandi-Perumal SR, Seils LK, Kayumov L, Ralph MR, Lowe A, Moller H, et al. Senescence, sleep, and circadian rhythms. Ageing Res Rev. 2002;1:559–604.View ArticlePubMedGoogle Scholar